Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study. — المؤلف: Powles, Thomas — JAMA oncology 20170926

المؤلف
Powles, Thomas
النشر
JAMA oncology 20170926
الوصف
e172411 p.
الموضوعات
Abdominal Neoplasms؛ Adult؛ Aged؛ Aged, 80 and over؛ Antibodies, Monoclonal؛ Antineoplastic Agents؛ B7-H1 Antigen؛ Carcinoma, Transitional Cell